Genmab A/SGMABNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-21.3%
5Y CAGR-16.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-21.3%/yr
vs -11.6%/yr prior
5Y CAGR
-16.6%/yr
Recent deceleration
Acceleration
-9.6pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 6.12 | +50.2% |
| 2024 | 4.07 | -47.0% |
| 2023 | 7.69 | -38.7% |
| 2022 | 12.54 | -34.9% |
| 2021 | 19.27 | +26.9% |
| 2020 | 15.19 | -9.3% |
| 2019 | 16.76 | -18.6% |
| 2018 | 20.57 | -22.8% |
| 2017 | 26.64 | -30.8% |
| 2016 | 38.50 | - |